[This review was originally posted at the Nieman Journalism Lab on Dec. 7, 2012.] Learning from The Daily’s demise: One […]
[This review was originally posted at the Nieman Journalism Lab Diflucan No Rx, on July 20, 2012.]
Yahoo's surprising hire: Yahoo's struggles over the past several years have been well documented, but the company made a big splash this week with its choice of a new CEO to try to lead its turnaround — top Google executive Marissa Mayer. Some observers, such as TechCrunch founder Michael Arrington and Wired's Steven Levy, saw the hiring of Mayer, who spent much of her time at Google heading up its search and location division, as an ideal fit for Yahoo. Others, like GigaOM's Mathew Ingram, Diflucan images, entrepreneur Mike Walrath, and Forrester's Shar VanBoskirk, said that as a technologist, Mayer makes a poor fit with a company whose future should lie in improving its media products, rather than its technological innovation.
The Guardian's Charles Arthur argued that by hiring Mayer, Order Diflucan from United States pharmacy, Yahoo is indeed making a clear statement that it's a technology company more than anything. Staci Kramer of paidContent made a similar point, saying the board opted to focus on improving its products over its media offerings — and it's harder to find good leaders in the former than the latter.
But as PandoDaily's Sarah Lacy noted, Yahoo has a long, ugly history with its headline-grabbing CEO hires and a lot of issues to address, Diflucan No Rx. Kara Swisher of All Things D posed several of those issues as questions to Mayer, wondering how she'll attract the top talent to engineer a turnaround while also making necessary cuts. Here at the Lab, Ken Doctor said the key question is what Mayer can bring to Yahoo that makes the company truly distinctive, and predicted that specialty will revolve around mobile media, Diflucan wiki.
Mayer told The New York Times she plans to focus on improving Yahoo's user experience, which, of course, could mean just about anything. The Atlantic's Megan Garber pointed out that the Internet's top priority for Yahoo seems to be getting its photo-sharing site Flickr fixed, and Julieanne Smolinski of XOJane urged Mayer to keep Yahoo "the dive bar of the Internet." Danny Sullivan of Search Engine Land looked at the implications for search, Diflucan no prescription, predicting that Mayer will actually start to sunset Yahoo's search effort.
The mixed legacy of Digg Diflucan No Rx, : Digg, the social-news network that had been considered at one point the vanguard of the movement into social media, reached what will probably be seen as its nadir last week when it was sold for a reported $500,000 to the tech firm Betaworks. (Including the prior sales of some of its assets, the total was probably actually at least $16 million.) The sale marked the end of a long downfall for Digg, which Megan Garber of The Atlantic chronicled by the numbers.
Betaworks plans to incorporate Digg into its personalized news aggregator, News.me, in an effort to reinvent both products, according to Mathew Ingram of GigaOM, Diflucan used for. Betaworks CEO John Borthwick said his company plans to revert Digg to startup mode. If Betaworks succeeds in reinvigorating Digg, PandoDaily's Erin Griffith noted that it could become the web's first full turnaround story.
The main questions that emerged in the wake of the deal had to do with why Digg fell so far, and what other organizations could learn from its demise, Diflucan No Rx. Digg's founder, Kevin Rose, argued that Digg failed because social media "grew up" as platforms like Facebook and Twitter did what Digg attempted to do, Generic Diflucan, only better. Paul Tassi of Forbes disputed that idea, arguing that Reddit is filling the exact niche Digg had hoped to fill.
Both Patricio Robles of Econsultancy and Jeff Bercovici of Forbes put together lists of lessons from Digg's collapse, with the importance of listening to your product's users emerging as a theme. That point was put most forcefully by Alexis Madrigal of The Atlantic, who wrote that Digg broke down because its community broke, meaning that "the technology that powered a once-massive social network is worth about $500, Diflucan duration,000. All the rest of the value derives from the people that use it."
A few writers pointed out that Digg did accomplish some important things during its run: Om Malik of GigaOM praised Digg Diflucan No Rx, as a company that "opened our eyes to the potential of the social web," and former Digg employee Aubrey Salaba of TechCrunch and former Digg devotee MG Siegler gave more personal appreciations of the site. Brian Morrissey of Digiday noted another important innovation Digg helped develop — ads that were actually a native part of the site's structure itself.
Journalism's dirty little quote approval secret: The New York Times reported this week on an alarming practice that's becoming commonplace among American campaign journalism — allowing sources to review and even change tape-recorded quoted comments. Several of the country's premier news organizations quickly responded to the exposé: Reuters and AP condemned the practice, The New York Times, Los Angeles Times, Where can i cheapest Diflucan online, and websites Buzzfeed and RealClearPolitics began reviewing their practices, and Politico's editor-in-chief expressed his concern.
The practice drew virtually universal disapproval from media observers. Perhaps the strongest condemnation came in The Guardian from Jeff Jarvis, who wrote that "When journalists give sources the opportunity to fix up what they've said, we become complicit in their spin, Diflucan No Rx. When we do so without revealing the practice, we become conspirators in a lie to the people we are supposed to serve: the public."
Others made similar points: Mother Jones' Kevin Drum said reporters are edging toward stenography, Dan Rather argued at CNN that this should prompt the public to question their trust in reporters, and Time's James Poniewozik and former newspaper editor John L. Robinson (among others) countered the objection that reporters get valuable stories through this tactic, Diflucan without prescription.
The Guardian's Ian Traynor warned American journalists with examples from Germany where requiring quote approval is standard practice. New York magazine's Joe Coscarelli said this gives live television the upper hand as "the real gladiator arena in today's YouTube-able, gaffe-centric political culture," and Carl Sessions Stepp of the American Journalism Review looked at the issue from sources' perspective, urging us to cut them a bit more slack when they do commit gaffes.
A new public editor at the Times: Marissa Mayer wasn't the only high-profile media/tech hire this week — The New York Times hired its first woman public editor Diflucan No Rx, , Margaret Sullivan, executive editor of the Buffalo News. Sullivan signed on for four years, Order Diflucan online overnight delivery no prescription, longer than any previous public editor. Poynter's Bill Mitchell and the Columbia Journalism Review's Sara Morrison talked to Sullivan about her plans for the position, which includes engaging in a more regular conversation with readers through the blog while keeping the more in-depth focus of the print column. You can also see a new Nieman Reports story of hers on the way the News handled a controversial crime story.
Sullivan told Mitchell and Michael Calderone of the Huffington Post that her experience as a woman would inform her perspective generally, but not in any specific way. Poynter's Mallary Jean Tenore argued that Sullivan's role as a woman may be more important than she's giving it credit for, and Sullivan wrote a blog post of her own what role her gender will and won't play in her public editing philosophy, Diflucan No Rx.
Sullivan also addressed the most controversial column of her predecessor, Arthur Brisbane, Diflucan dosage, telling Media Matters' Joe Strupp that she does indeed believe the Times should be a "truth vigilante." Isaac Chotner of The New Republic urged her not to follow Brisbane's example in indulging the inane complaints of readers. But tech pioneer Dave Winer, however, argued that the Times' public editor should identify more closely with the public, rather than the paper. "A good Public Editor is over-the-top critical of the news organization. He or she errs on the side of being fair to the Public and unfair to the news organization. The Public Editors the Times has hired have flipped it the other way around, Kjøpe Diflucan på nett, köpa Diflucan online, " he wrote.
A place for outsourcing in journalism?: Things just keep getting worse for local content provider Journatic in the wake of the revelation a few weeks ago that it's been using fake bylines on some pieces. Diflucan No Rx, The Chicago Tribune, which has invested in Journatic and had turned its TribLocal content over to the company, suspended its use of Journatic content after discovering some plagiarism in it. (Its newsroom is taking back over the TribLocal work.) Poynter also found more than 350 Journatic pieces for the Houston Chronicle with fake bylines, prompting internal reviews of Journatic content by both the Chronicle and its sister paper, the San Francisco Chronicle.
Meanwhile, Journatic sent an internal memo urging writers not to plagiarize or lie about their names or where they're working from. And one of Journatic's executives said he resigned because of conflicts over the company's ethical values, Diflucan brand name, though Journatic said it was about to fire him anyway. (Virtually all of those links are via Poynter's excellent coverage of the saga.)
Opinions on the dangers of semi-automated, outsourced journalism like Journatic's continued to flow in, including a discussion on the Bay Area's KQED radio and a Miami Herald column by Edward Wasserman. Others cautioned not to dismiss outsourced or content-farmed journalism out of hand: Poynter's Craig Silverman said this type of model is inevitable but needs to be done better, and GigaOM's Mathew Ingram said Journatic is just one (very flawed) way of trying to solve the problem of paying for commodity journalism, Diflucan No Rx. Spot.Us founder David Cohn outlined some lessons for journalists about the difficulties of building a content business on local data while trying to negotiate long-held journalism customs.
Reading roundup: It's been a really, Where can i buy Diflucan online, really busy week in media and tech. Here are a few of the stories that might have gotten lost in the shuffle:
— I noted last week that News Corp. is considering shutting down its daily tablet publication, The Daily. The publication launched a weekend edition Diflucan No Rx, , WKND, last weekend, and several analysts looked at why The Daily has struggled: The Next Web looked at the money, paidContent looked across some of the deeper issues involved, and Gawker's Hamilton Nolan offered a simpler rationale. Media analyst Frederic Filloux gave the most thorough explanation, calling The Daily "a sophisticated container for commodity news."
— This week's paywall notes: A report found that half of the revenue in a newspaper paywall comes in the first three months, and the Australian site Mumbrella questioned whether paywalls are changing the way reporters write. Meanwhile, Washington Post publisher Don Graham explained why his paper will never institute a paywall.
— A new study by Pew's Project for Excellence in Journalism detailed the news environment that's emerging on YouTube. The Washington Post focused on the rise of news' popularity there, and the Lab's Adrienne LaFrance offered a great analysis of what works and what doesn't for news on YouTube.
Similar posts: Lipitor Price. Flagyl For Sale. Bactrim Mg. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Diflucan No Rx. Diflucan No Rx. Diflucan No Rx. Diflucan from canadian pharmacy. Diflucan no prescription. Diflucan dosage.
[This review was originally posted at the Nieman Journalism Lab Retin A Cost, on May 27, 2011.]
Censorship, the law, and Twitter: If we hadn't already learned how social media are opening the traditional media's gatekeeping role to the masses, we got a pretty good object lesson this week in Britain. Here's what happened: To keep the British tabloids from digging into an alleged affair with a reality TV star, Manchester United soccer star Ryan Giggs took out a British court provision called a super-injunction that prohibits media from identifying him and reporting on both the story and the very fact that a super-injunction exists.
But the super-injunction was no match for Facebook, Twitter, and soccer forums, where thousands of people talked about Giggs and the affair in spite of (and because of) the order, where can i cheapest Retin A online. Since then, a Scottish newspaper and a member of Parliament have both named Giggs, rendering the super-injunction essentially ineffective and causing quite a bit of handwringing over whether gag orders are a lost cause in the Twitter age, and whether or not that's a good thing.
Giggs sued Twitter for the breach, Taking Retin A, and some members of Parliament started looking for ways to control the site. Prime Minister David Cameron said Twitter made Britain's injunctions "unfair" and "unsustainable" for traditional media and urged Parliament to change them, Retin A Cost. Some people, including World Wide Web creator Tim Berners-Lee and the Guardian's Richard Hillgrove, said the problem lies with Twitter, not the law, with Hillgrove (rather absurdly) suggesting a delay mechanism to monitor posts before they go up: "Twitter and Facebook are not blank sheets of paper. They are media publishers like any other."
Others faulted the law instead: At the Guardian, Retin A steet value, Dan Gillmor said it allows the wealthy to play by different rules, and the Telegraph'sHarry Mount said that thanks to the web, "a form of people power has been effectively absorbed into that new body of privacy law." The Vancouver Sun's Mario Canseco documented the failure of gag orders in the Internet age in Canada, and Mathew Ingram of GigaOM advised courts and governments to quit trying to enforce antiquated laws, saying they "may not like the implications of a totally distributed real-time information network, Purchase Retin A for sale, but they are going to have to start living with it sooner rather than later."
Then, of course, there's the question of whether the anonymous online super-injunction violators have any legal repercussions to worry about. As the New York Times noted, Twitter has been resistant to turning over its users' identities in the past, though a Twitter official said this week it will hand over user info to the authorities if it's legally required to. But even with Twitter's compliance, where can i order Retin A without prescription, there would still be hurdles to clear in identifying users, the Telegraph explained.
iPad channels for big and small media Retin A Cost, : Several big-media publications neared or hit iPad milestones this week: On stage at the TechCrunch Disrupt conference, The Daily's Greg Clayman said it's nearing a million downloads since it was launched in January. Clayman wouldn't say how many paid subscribers the News Corp. iPad-only publication has (a far more interesting figure in determining The Daily's viability), but Adweek's Lucia Moses said The Daily will announce its number of paid downloads — it only started charging in March — once it hits a "target level."
Meanwhile, Cheap Retin A no rx, Wired and GQ were made available for in-app subscriptions through Apple App Store this week, after their owner, Condé Nast, became one of the first major publishers to strike a deal with Apple for in-app subscriptions earlier this month. Another major publication, Playboy, launched an iPad subscription outside the App Store, buy Retin A online cod, because it obviously has some difficulty complying with Apple's "no nudity" policy.
Playboy's app is essentially an iPad-optimized website, which might seem like a tempting option for publishers who don't want to deal with Apple's restrictions, but as Mashable and GigaOM explained, Playboy might be uniquely positioned to pull this off where others can't. GigaOM's Mathew Ingram looked at those cases and weighed the pluses and minuses for publishers of getting into bed with Apple, Retin A Cost. Buy Retin A from canada, Of course, big publishers aren't the only ones getting into the iPad game: At paidContent, Ashley Norris, CEO of a small publishing company that just released an iPad app, argued that indie publishers could play a key role in developing the tablet magazine. Flipboard is a pretty ideal model for those publishers: It's valued at $200 million, and SiliconAngle's Tom Foremski said it exemplifies the current en vogue tech-bubble business plan: "find free content and organize it into a useful interface." That niche might not play as big of a part in the iPad market as we think, buy cheap Retin A, though: As Poynter's Jeff Sonderman noted via ReadWriteWeb, news apps make up only 3% of all the apps in the App Store.
Driving more traffic from Facebook: Facebook has been working hard lately to cozy up to news organizations, and this week it provided some statistics that may have some of those organizations looking more closely at integrating Facebook into their sites. According to stats Search Engine Land got from Facebook (so grain of salt, Taking Retin A, etc.), the average media site integrated with Facebook has gotten a 300% jump in Facebook referral traffic, and ABC News, the Washington Post, and the Huffington Post have all reportedly doubled their traffic from Facebook since adding social plugins. Retin A Cost, Meanwhile, Fortune's Peter Lauria talked to Facebook's Vadim Lavrusik about the possibility of news orgs charging on Facebook using Facebook credits, like some Facebook games do now.
As it's been known to do, Facebook played a big role in the aftermath of another natural disaster this week when a tornado hit Joplin, Retin A dose, Missouri. The local newspaper, the Joplin Globe, told Poynter about how they set up a Facebook page to help people find family and friends in the tornado's wake.
Elsewhere in social media and news, Is Retin A safe, the New York Times experimented this week with a human-powered Twitter feed, as opposed to its usual mostly automatically driven style. The Times' Liz Heron (and a couple of other newspaper social media editors) talked to Poynter's Jeff Sonderman about their Twitter strategies, and Jessica Roy of 10,000 Words looked at how the experiment changed the Times' Twitter feed. Heron also revealed the Times' informal social media guidelines at the BBC's Social Media Summit: "Use common sense and don't be stupid."
Reading roundup: Not a lot of big future-of-news stories this week, a several smaller things worth keeping an eye on:
— Google notified publishers late last week that it's abandoning its project to scan and archive hundreds of years of old newspapers, Retin A Cost. The Atlantic's Adam Clark Estes lamented the decision, and Paul Balcerak urged newspapers to pick up where Google left off, Retin A images.
— This week's AOL/Huffington Post bits and pieces: Huffington Post Canada has been launched, AOL's Daily Finance has been made over, and some HuffPo staff are reportedly leaving because they're upset with how the AOL/HuffPo marriage has gone so far. Meanwhile, even though AOL's content is free, Retin A reviews, CEO Tim Armstrong expressed his general belief in paid content online.
— Ben Huh of the Cheezburger network of comedy sites announced he's working on what he's calling the Moby Dick Project — an effort to reform the way news is presented and consumed online. ReadWriteWeb gave more details Retin A Cost, of the type of software he's developing.
— A couple of addenda to last week's linking discussion: Former Wall Street Journal columnist Jason Fry wrote about solving the workflow issue at newspapers, and at the Guardian, Dan Gillmor called out lazy linking — linking to a summary, rather than the original piece — in online aggregation.
— CUNY j-prof Jeff Jarvis made a case for news as conversation and the value of comments, rx free Retin A, and at 10,000 Words, Alex Schmidt wrote about the way poisonous online comments can affect reporters.
— Finally, Canadian media consultant Ken Goldstein issued a paper looking at decline circulation of newspapers in Canada, the U.S., and the U.K. He included a possibly remarkably prescient 1964 quotation by media theorist Marshall McLuhan: "The classified ads (and stock-market quotations) are the bedrock of the press. Should an alternative source of easy access to such diverse daily information be found, the press will fold.".
Similar posts: Purchase Glucophage. Purchase Bactrim. Glucophage Cost. Doses Zoloft work. Ordering Bactrim online. Cephalexin recreational.
Trackbacks from: Retin A Cost. Retin A Cost. Retin A Cost. Retin A long term. Retin A blogs. Retin A class.
[This review was originally posted at the Nieman Journalism Lab Glucophage Price, on Feb. 11, 2011.]
AOL scoops up Arianna: The week's biggest media story was broken just a couple of hours after the Super Bowl on Sunday, when Kara Swisher of All Things D reported that AOL would buy The Huffington Post for $315 million (here's video of her interview with Arianna Huffington and AOL CEO Tim Armstrong). Swisher's post and this New York Times article provide just about all the background information you should need on the deal, along with The Huffington Post's press release and Huffington's column on the acquisition. Glucophage canada, mexico, india, The deal was seen by many as a bold one — a "fourth-quarter Hail Mary pass," as The New Yorker's Ken Auletta wrote — and reaction on the web (also summed up well by GigaOM's Mathew Ingram) was decidedly mixed. The thumbs-ups came from a eclectic mix of critics: Henry Blodget of Business Insider called it a smart risk, Reuters' Felix Salmon and All Things D's Peter Kafka said the two companies' needs fit each other well, with AOL getting a clear editorial voice (Salmon) and a "content-making machine" (Kafka). CUNY j-prof Jeff Jarvis said what AOL will find most valuable in HuffPo will not be content, but "a new cultural understanding of media that is built around the value of curation, the power of peers, the link economy, passion as an asset, and celebrity as a currency."
There were also plenty of people who shook (or at least scratched) their heads at the deal, including many of HuffPo's own readers and writers, Glucophage Price. Shira Ovide of The Wall Street Journal called it AOL's admission that its content strategy isn't working, and industry analyst Alan Mutter said AOL overpaid, online buy Glucophage without a prescription. The Guardian's Jemima Kiss blasted the move as "soullessly commercial," and Salon vet Scott Rosenberg contended that Huffington's once-distinctive brand will dissolve into AOL's bland corporatism. PaidContent's David Kaplan, Dan Lyons, and Om Malik of GigaOM both pointed to advertising struggles, Discount Glucophage, with Malik arguing that AOL has "not yet come to terms with the futility of chasing page views."
A few themes came up repeatedly in commentary about the two companies; one was HuffPo's expertise in that notorious (some would say dark) art known as search engine optimization. Salon's Alex Pareene declared the new organization "the single largest SEO-gaming operation ever created" and the LA Times' James Rainey explained the appeal that the Post's SEO skills bring. Slate's Farhad Manjoo (who wins this week's award for best lead) made the case that AOL/HuffPo's SEO-heavy strategy is risky in the long-term because "they won't be able to fool the computers forever." (Capital New York's Tom McGeveran made a similar point Glucophage Price, .) HuffPo's new AOL corporate empire-mate, Paul Carr of TechCrunch, reaffirmed his hatred for HuffPo's SEO tactics but said the deal could still be a good one for AOL.
The second theme was the fact that the Post doesn't pay most of its writers, a strategy that Tim Rutten of the Los Angeles Times likened to "a galley rowed by slaves and commanded by pirates." Dan Gillmor's tone was a bit milder, but he, Glucophage samples, too, urged Huffington to start paying her most productive bloggers, and Northeastern j-prof Dan Kennedy wondered whether bloggers might be less willing to go unpaid under a mega-corporation like AOL. Reason's Matt Welch defended Huffington against Rutten's charges, and Time's James Poniewozik said it's possible AOL/HuffPo could be signaling a move toward more expensive, Australia, uk, us, usa, quality content.
A few miscellaneous pieces of sharp commentary: GigaOM's Mathew Ingram said AOL needs HuffPo to help its other online content initatives figure out how the Internet works, and media analyst Ken Doctor saw AOL/HuffPo as a potential free alternative to Rupert Murdoch's steadily building paid-content empire. There were also plenty of posts about what the political viewpoint of the new organization would be, and while I haven't waded into that discussion, I do like NYU j-prof Jay Rosen's concept of "ideological innovation" in online journalism.
Changing coverage of a changing world: As the protests in Egypt have continued, so has the conversation about its media-related implications, and just as in last week, much of the talk centered on Al Jazeera, Glucophage Price. The New York Times examined the network's influence on the protests, Glucophage natural, as well as its efforts to gain more access to American viewers. Throughout the past two weeks, as the Lab's Justin Ellis and Twitter's Robin Sloan pointed out, Al Jazeera has been using social media to distribute its news to American audiences. Meanwhile, Glucophage overnight, Sheila Carapico at Foreign Policy argued that Al Jazeera and other TV networks can't give us a full picture of what's going on in Egypt.
There's been other fantastic journalism arising from the Egyptian protests, including the work of NPR's Andy Carvin to curate news and voices of the conflict on Twitter. Glucophage Price, In an illuminating interview with The Atlantic, Carvin argued that curation — the process of capturing the most elements of a story from various sources and passing them along — has always been a part of journalism. In a more academic piece at the Lab, USC grad student Nikki Usher explained how the protests are expanding the idea of a media event, with social media, webstreams, Glucophage cost, and the mainstream media "all working together to create a much larger, more nuanced picture of the live broadcasting of history."
The debate over social media's role in revolutions continued to roil, with several more writers responding to Malcolm Gladwell's brief New Yorker post arguing that the role Twitter & Co. in social activism like the Egyptian protests is overrated. UT-Dallas prof David Parry, Glucophage images, The Awl's Maria Bustillos, new media exec Rex Hammock, UMBC prof Zeynek Tufekci, and web philosopher David Weinbergerall weighed in with their rejoinders to Gladwell, in a discussion that Washington grad student Deen Freelon has mapped out far more expertly than I could.
Speeding up The Daily: The negative buzz around The Daily that began last week continued to pile up this week, leading to, Glucophage use, among other things, a "We're listening" blog post by the new "tablet newspaper." One of the issues that drew criticism was The Daily's long load time, as John Gruber of Daring Fireball compared it unfavorably to Flipboard, and paidContent's Staci Kramer explained her own loading glitches. Both Gruber and Kramer argued that while it seem minor, load time is a big deal to users, and The New York Times' Nick Bilton made a similar point: By being too slow and bulky, digital magazines like The Daily "almost defeat one of their main intended purposes, the promise of instant access to content and information."
The reviews kept pouring in as well, led by an insightful critique of The Daily's design by Stephen Coles at Fonts In Use, Glucophage Price. The primary criticism continued in the same vein as last week: The Daily's content just doesn't cut it. John Gapper of the Financial Times and Skip Ferderber of Crosscut made the point this week, Glucophage wiki, and Poynter's Damon Kiesow noted that new content is tough to find. Paul Davis of Shareable also chimed in with a criticism of The Daily's shortcomings with limited sharing options.
But there were a few who were generally impressed with The Daily's first week, including MinnPost's John Dreinan and industry analyst Alan Mutter, who liked its concise storytelling, multimedia integration and interactive advertising. Damon Kiesow and The Columbia Journalism Review's Lauren Kirchner both looked to other media efforts for lessons for The Daily — Kiesow to various other iPad apps, and Kirchner to the mid-1990s debut of Slate and Salon, Glucophage no prescription.
Gawker evolves the blog: We've been hearing about it since November, and this week Gawker officially launched its redesign, which reflects to a more magazine-style emphasis from a purer blog format. The Lab's Megan Garber captured what the move means Glucophage Price, particularly in terms of Gawker's advertising strategy, explaining how it's appropriated parts of the TV and magazine models to capitalize on its brand as a whole: "It’s moved, it seems, beyond simply selling its readers to advertisers. Now, it is simply selling itself."
Former Gawker Media contributor Latoya Peterson pointed to the outrage by Gawker blogs' readers and used it to argue that Gawker's new, My Glucophage experience, more controlled design is subverting the fast-posting, skim-friendly style it helped make a blogging standard. Rex Sorgatz was also skeptical of the change, asserting that the redesign would have to be rolled back or reworked within months and challenging anyone to bet him otherwise — a wager that was taken up by Gawker chief Nick Denton himself, using pageviews as the determining factor.
TBD takes a step back: TBD, a online local news operation based in Washington, real brand Glucophage online, D.C., debuted last August to much fanfare, but it took a major hit when the Washington Post reported that its owner Robert Allbritton (who also owns Politico) would have his local TV station WJLA take it over. TBD editor-in-chief Erik Wemple told the Lab's Megan Garber that the move wouldn't be as bad as it appeared, but it was still widely interpreted as "a retreat from the original vision of TBD, Purchase Glucophage online no prescription, " in the Post's words. Jim Brady, the site's former general manager, called it "not good news," and NYU j-prof Jay Rosen summed it up as "the TV guys won."
In the wake of the news, several observers expressed their frustration: Media consultant Mark Potts ripped Allbritton for not allowing the site breathing room to innovate, and media analyst Janet Coats held it up as an example of old media's resistance to change. Terry Heaton and Lost Remote's Cory Bergman used the episode to talk about the tensions involved when TV stations are affiliated with online media efforts, Glucophage Price.
Reading roundup: There's still quite a bit to get to, but I'll run through it quickly:
— Re Wikileaks: New York Times executive editor Bill Keller edged toward defining WikiLeaks as something a lot like journalism, The Nation's Greg Mitchell explained why the mainstream media is skeptical of WikiLeaks, the Personal Democracy Forum's Micah Sifry and NYU prof Clay Shirky gave some reasons for WikiLeaks' revolutionary nature, and at The Guardian, Evgeny Morozov argued that WikiLeaks can't continue much longer in its current form.
— At the National Sports Journalism Center, Jason Fry wrote a wonderful piece talking about how much less valuable scoops have become in a commoditized news world, and what journalists should do as a result. Craig Calcaterra of the baseball blog Hardball Talk expanded on the idea, offering a vision for the role of bloggers and reporters in a commodity-news environment.
— Two pieces to chew on this weekend, one short and one long: Dave Winer's plea to news organizations to join their communities online, and The New Yorker's Adam Gopnik's musings on the Internet and our interior lives.
Similar posts: Glucophage Mg. Retin A For Sale. Flagyl Over The Counter. Retin A mg. Discount Cipro. Buy Zoloft online cod.
Trackbacks from: Glucophage Price. Glucophage Price. Glucophage Price. Where can i find Glucophage online. Glucophage natural. Glucophage samples.
[This review was originally posted at the Nieman Journalism Lab Bactrim Cost, on Feb. 4, 2011.]
Al Jazeera, the network, and social activism: For the last week, the eyes of the world have been riveted to the ongoing protests in Egypt, and not surprisingly, the news media themselves have been a big part of that story, Bactrim interactions, too. Many of them have been attacked by President Hosni Mubarak's lackeys, but the crisis has also been a breeding ground for innovative journalism techniques. Mashable put together a roundup of the ways journalists have used Twitter, Facebook, streaming video, Bactrim without a prescription, Tumblr, and Audioboo, and the Lab highlighted reporting efforts on Facebook, curation by Sulia, and explainers by Mother Jones. Google and Twitter also created Speak to Tweet to allow Egyptians cut off from the Internet to communicate.
But the organization that has shined the brightest over the past 10 days is unquestionably Al Jazeera, Bactrim Cost. The Qatar-based TV network has dominated web viewing, and has used web audio updates and Creative Commons to get information out quickly to as many people as possible, Bactrim long term.
Al Jazeera also faced stiff censorship efforts from the Egyptian government, which stripped its Egyptian license and shut down its Cairo bureau, then later stole some of its camera equipment. Through it all, the broadcaster kept up live coverage that online and offline, was considered the most comprehensive of any news organization. Low dose Bactrim, As Lost Remote's Cory Bergman pointed, Al Jazeera's coverage showed the continued power of compelling live video in a multimedia world.
Salon's Alex Pareene called Al Jazeera's coverage Bactrim Cost, an indictment on the U.S.' cable networks, and CUNY j-prof Jeff Jarvis and others urged cable companies to carry Al Jazeera English. Tech pioneer Doc Searls used the moment as a call for a more open form of cable TV: "The message cable should be getting is not just 'carry Al Jazeera,' but 'normalize to the Internet.' Open the pipes. Give us à la carte choices. Let us get and pay for what we want, not just what gets force-fed in bundles."
The protests also served as fresh fuel for an ongoing debate about the role of social media in social change and global political activism. Several critics — including Wired's David Kravets, Bactrim no rx, The New Yorker's Malcolm Gladwell, and SUNY Oswego prof Ulises Mejias— downplayed the role of social media tools such as Twitter in protests like Egypt's. Others, though, countered with a relatively unified theme: It's not really about the media tools per se, but about the decentralized, hyperconnected network in which they are bound up. J-profs Jeremy Littau and Robert Hernandez, along with GigaOM's Mathew Ingram, wrote the most thoughtful versions of this theme, and they're all worth checking out, Bactrim Cost.
Tepid reviews for The Daily: Within the bubble of media geeks, one story dominated the others this week: On Wednesday, Rupert Murdoch's News Corp. released The Daily, the first daily updated news publication produced specifically for the iPad. Bactrim photos, If you can't get enough coverage of The Daily, go check out Mediagazer's smorgasbord of links. I'll try to offer you a digestible (but still a bit overwhelming, I'll admit) summary of what people are saying about it.
Leading up to Wednesday's launch, Poynter's Damon Kiesow found many of the people who are working for the heretofore secretive publication, and media analyst Alan Mutter and All Things Digital's Peter Kafka examined the reasons why it might or might not take off. Bactrim Cost, Once the app was released Wednesday afternoon, the reviews came pouring in.
First, buy Bactrim online cod, the good: The first impressions of most of the digital experts polled by Poynter were positive, with several praising its visual design and one calling it "what I’ve always hoped newspapers would do with their tablet editions." PaidContent's Staci Cramer was generally complimentary, and The Guardian's Ian Betteridge gave it a (not terribly enthusiastic) "buy."
Most of the initial reviews, though, were not so kind. Much of the 'meh' was directed at lackluster content, Where can i find Bactrim online, as reviewer after reviewer expressed similar sentiments: "a general-interest publication that is not generally interesting" (The Columbia Journalism Review); "Murdoch’s reinvention of journalism looks a lot like the one before it" (Macworld); "fairly humdrum day-old stories that you might read in, well…a regular old printed newspaper" (Mathew Ingram); "little [of Murdoch's money], it appears, has been invested in editorial talent" (Mashable); "the Etch A Sketch edition of Us Magazine" (Alan Mutter); "barely brings digital journalism into the late 20th century, much less the 21st" (Mark Potts).
The bulk of that criticism seemed to be built on two foundational questions, asked by the Lab's Joshua Benton, which The Daily has apparently yet to answer convincingly: "Who is The Daily trying to reach, order Bactrim from mexican pharmacy. What problem is it trying to solve?" TechCrunch (and several of the above reviewers) asked similar questions, and GigaOM's Darrell Etherington attempted an answer, arguing that it's not for the obsessively-Twitter-checking news junkies, but iPad users struggling to adjust to life after newspapers.
A few other issues surrounding The Daily that drew attention: One was its separation from the web by virtue of its place within the proprietary iTunes Store and iPad, as well as the complete lack of links in or out, Bactrim Cost. (That hasn't stopped an authorized daily index of links to the web versions of articles from springing up, though.) Salon alum Scott Rosenberg and j-prof Dan Kennedy led the charge against the walled garden, Bactrim dosage, while the Lab's Megan Garber pointed out the draconian anti-aggregation language on The Daily's AP content, and Justin Ellis wondered how user engagement will work in that closed environment.
Then there were the economics of the publication: Media analyst Ken Doctor had two good sets of questions about what it will take for The Daily to financially succeed (the latter is more number-crunchy). Jeff Jarvis also looked at some possible numbers, and media consultant Amy Gahran chastised Murdoch for investing so much money in the venture. Gahran also looked at the hazards of dealing with Apple, and paidContent's Staci Kramer noted that Murdoch wants Apple to lower its share of the subscription revenue. Bactrim Cost, And on the News Corp. front, Bactrim alternatives, Slate's Jack Shafer wrote about the role Murdoch's impatience will play in its fate, and Subhub's Evan Radowski gave us a history lesson on News Corp. initiatives like this one.
Apple strikes against e-publishers: In its ongoing tightening of App Store access and regulations, Apple made a significant move this week by rejecting a Sony iPhone app that would have allowed users to buy e-books from the Sony Reader Store. GigaOM's Mathew Ingram did a great job of putting the decision in the context of Apple's past moves, No prescription Bactrim online, explaining why they make good business sense: "What’s the point of controlling a platform like the iPhone and the iPad if you can’t force people to pay you a carrying charge for hosting their content and connecting them with their customers?"
But others (even at GigaOM) were more skeptical. Jason Kincaid of TechCrunch said the decision underscores the downside of closed content platforms, and posited that it's the first shot in a war between Apple and Amazon's Kindle, and Slate's Farhad Manjoo urged Amazon to pull its Kindle app out of the App Store. In another widely expected move along the same lines, Apple also told publishers that within two months, any app that doesn't take payments through its iTunes Store would be rejected, Bactrim Cost.
AOL follows Demand's content-farming path: We talked last week about Demand Media's explosive IPO and Google's intention to make content farms harder to find in searches, and we have a couple of updates to those issues this week. First, Seamus McCauley of Virtual Economics explained why he's skeptical about Demand's true valuation, not to mention its accounting methods, doses Bactrim work. And while Google's algorithm limiting content farms is not yet live, search engine startup Blekko has banned many content farm domains, including Demand's eHow, from its search results. Meanwhile, the debate over Demand continued, Buy no prescription Bactrim online, with Adotas' Gavin Dunaway and MinnPost's John Reinan delivering this week's broadsides against the company. Bactrim Cost, AOL hasn't been talked about as a content farm too much as of yet, but that may change after Business Insider's publication this week of a leaked internal document called "The AOL Way," which reads a lot like the textbook content farm strategy guide. GigaOM's Mathew Ingram and Fortune's Dan Mitchell blasted the plan, with Ingram asserting that "the chasing of eyeballs and pageviews is a game of constantly diminishing returns." Martin Bryant of The Next Web, on the other hand, said AOL's model is not a misguided, diabolical plan, but "an inevitable, turbo-powered evolution of what’s happened in the media industry for many years."
Reading roundup: A few things to check out this weekend while you're most likely snowed in somewhere:
— This week's WikiLeaks update: Julian Assange sat down with 60 Minutes for an interview (there's also a video on what it took to make that happen), buy cheap Bactrim, WikiLeaks was nominated for the Nobel Peace Prize, The Guardian's Alan Rusbridger gave his own account about working with WikiLeaks, and NYU's Adam Penenberg made the case for Assange as a journalist. Reuters also profiled the new WikiLeaks spinoff OpenLeaks.
— A few paid-content notes: The New York Times isn't releasing details of its paywall plan just yet, but it is fixing technological glitches with the system right now, while Media Week reported that some industry analysts are skeptical of its chances. Meanwhile, the Philadelphia Inquirer and Daily News announced they'll start offering an e-edition to paying subscribers.
— GigaOM founder Om Malik wrote a simple but insightful guide to creating a successful consumer Internet service, focusing on three elements: A clear purpose, ease of use, and fun.
— Harvard prof David Weinberger has a short, thought-provoking post offering a 21st-century update on Marshall McLuhan's famous "The medium is the message" aphorism: "We are the medium." It's a simple idea, but it has some potentially profound implications, a few of which Weinberger begins to flesh out.
Similar posts: Bactrim Dosage. Zoloft Cost. Bactrim Price. Cipro no prescription. Taking Retin A. Order Flagyl from mexican pharmacy.
Trackbacks from: Bactrim Cost. Bactrim Cost. Bactrim Cost. Purchase Bactrim online no prescription. Bactrim australia, uk, us, usa. Where can i find Bactrim online.